DRUG-AND-DROP
DEAD

Serial Number

97721021

Owner

Tome Biosciences, Inc.

Attorney

Lisa Greenwald-Swire

Filing Date

Dec 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DRUG-AND-DROP Trademark

Serial Number: 97721021

DRUG-AND-DROP is a trademark filed by Tome Biosciences, Inc. on December 16, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Tome Biosciences, Inc. (13 trademarks)

100 Talcott Avenue
Watertown, MA 02472

Entity Type: 03

BASECAMP RESEARCH LTD

Unit 315, Clerkenwell Workshops
London EC1R0AT , GB

Entity Type: 24

Trademark Details

Filing Date

December 16, 2022

Registration Date

Not Registered

Published for Opposition

January 9, 2024

Goods & Services

Providing medical and healthcare information in the field of gene sequencing, gene editing, and gene insertion technologies; Providing medical and healthcare information regarding gene therapies and cell therapies

Biological preparations for scientific use for use in gene therapy, gene editing, gene insertion, and cell therapy

Medical and scientific research; Medical research and development in the fields of genomic medicine, genome engineering, and cell engineering; Scientific research and development in the field of genomic medicine, genome engineering, and cell engineering; Research and development of pharmaceutical preparations for gene therapy, gene editing, gene insertion, and cell therapy; Providing medical and scientific research information in the fields of genomic medicine, genome engineering, and cell engineering

Pharmaceutical preparations and biological preparations for medical treatment for use in gene therapy, gene editing, gene insertion, and cell therapy for the treatment of genetic disorders; Pharmaceutical and biological preparations for the treatment of genetic disorders; Pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, modification, regulation, and repair for use in human therapeutic

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 6, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 6, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 30, 2025 EXRA
SOU EXTENSION 3 GRANTED
Jul 30, 2025 EX3G
SOU EXTENSION 3 FILED
Jul 30, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jul 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 2, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 1, 2025 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 24, 2025 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2025 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 5, 2025 ASGN
SOU TEAS EXTENSION RECEIVED
Mar 4, 2025 EEXT
SOU EXTENSION 2 FILED
Mar 3, 2025 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 5, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 5, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 5, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 5, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 5, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 20, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 2, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 2, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 2, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 2, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 28, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 2, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 2, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 2, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2023 NWOS
NEW APPLICATION ENTERED
Dec 20, 2022 NWAP